emtricitabine/tenofovir disoproxil KRKA d.d.

emtricitabine; tenofovir disoproxil succinate · KRKA, d.d., Novo mesto

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for emtricitabine/tenofovir disoproxil KRKA d.d., covering 2025-02-05 to 2025-02-05. Get the full timeline:

Most recent: EMA Authorised: Emtricitabine/Tenofovir disoproxil Krka d.d. (emtricitabine;tenofovir disoproxil succinate) — KRKA, d.d., Novo mesto